Background:
The purpose of this study was to evaluate
the impact of glucose levels on admission, on the risk of 30-day major adverse
cardiovascular events (MACEs) in patients with acute myocardial infarction (AMI),
and to assess the difference in outcome between ST-segment elevation myocardial
infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI)
patients. Methods: This study was a post hoc analysis of the Acute
Coronary Syndrome Quality Improvement in Kerala Study, and 13,398 participants
were included in the final analysis. Logistic regression models were used to
assess the association between glucose levels on admission and the risk of 30-day
MACEs, adjusting for potential confounders. Results:
Participants were divided according to the
glucose quintiles. There was a positive linear association between glucose levels
at admission and the risk of 30-day MACEs in AMI patients [adjusted OR (95% CI):
1.05 (1.03, 1.07), p
Announcements
Open Access
Original Research
Elevated Glucose on Admission Was an Independent Risk Factor for 30-Day Major Adverse Cardiovascular Events in Patients with STEMI but Not NSTEMI
Linlin Ma1, Yanan Li2, Junyu Pei3,4, Xiaopu Wang3,4, Keyang Zheng1, Zixu Zhao5, Jiafu Yan6, Rufei Liu1, Tianzhu Zhao1, Yuxuan Wei1, Wenli Cheng1,*
Show Less
1
Center of Hypertension, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China
2
School of Public Health, Brown University, Providence, RI 02903, USA
3
Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, 410011 Changsha, Hunan, China
4
Department of Biochemistry and Molecular Biology, The Libin Cardiovascular Institute of Alberta, The University of Calgary, Health Sciences Center, Calgary, AB T2N 4N1, Canada
5
Department of Cardiovascular Medicine, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China
6
Department of Cardiology, Affiliated Hospital of Yangzhou University, Yangzhou University, 225000 Yangzhou, Jiangsu, China
*Correspondence: Anzhen_HTN@163.com (Wenli Cheng)
Rev. Cardiovasc. Med. 2024, 25(2), 46;
https://doi.org/10.31083/j.rcm2502046
Submitted: 13 August 2023 | Revised: 19 October 2023 | Accepted: 24 October 2023 | Published: 29 January 2024
Copyright: © 2024 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract
Keywords
glucose
major adverse cardiovascular events
ST-elevation myocardial infarction
non-ST-elevation myocardial infarction
Figures
Fig. 1.